Alliance Global Partners analyst Brian Kinstlinger lowered the firm’s price target on Healwell AI (HWAIF) to C$2.25 from C$2.75 and keeps a Buy rating on the shares following the Q3 report. The company posted its second profitable quarter, the analyst tells investors in a research note. It fine tuned estimates post the print.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HWAIF:
- HEALWELL AI Reports Record Q3 Revenue and Strategic Growth
- HEALWELL AI: Transformation to a High-Growth Enterprise AI Leader Warrants Buy Rating
- HEALWELL AI Streamlines Operations with Strategic Divestments and Joint Venture
- HEALWELL AI and Lean Business Services Partner to Advance AI Healthcare in the Middle East
- HEALWELL AI to Release Q3 2025 Financial Results